CVA Family Office’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.4K Hold
834
﹤0.01% 592
2026
Q1
$59.4K Buy
834
+100
+14% +$7.89K 0.01% 562
2025
Q4
$60.2K Buy
734
+89
+14% +$6.93K 0.01% 524
2025
Q3
$48.4K Sell
645
-18
-3% -$1.34K 0.01% 557
2025
Q2
$49.1K Sell
663
-48
-7% -$3.34K 0.01% 549
2025
Q1
$57.4K Buy
711
+43
+6% +$3.7K 0.01% 496
2024
Q4
$52.2K Buy
668
+40
+6% +$3.4K 0.01% 516
2024
Q3
$58.9K Buy
628
+24
+4% +$2.01K 0.01% 477
2024
Q2
$47.1K Sell
604
-6
-1% -$489 0.01% 507
2024
Q1
$55.5K Buy
610
+6
+1% +$499 0.01% 471
2023
Q4
$46.7K Buy
+604
New +$42.3K 0.01% 497
2023
Q3
Sell
-623
Closed -$50.6K 516
2023
Q2
$50.6K Sell
623
-107
-15% -$8.54K 0.01% 449
2023
Q1
$59.9K Buy
+730
New +$52.1K 0.01% 404

Other funds holding GEHC

CVA Family Office's GEHC Position: Q2 2026 in Review

CVA Family Office held its GE HealthCare (GEHC) position steady in Q2 2026 at 834 shares worth $53.4K. The position accounts for ﹤0.01% of the portfolio, ranked #592.

CVA Family Office first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $60.2K in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • CVA Family Office held 834 shares of GE HealthCare worth $53.4K as of Q2 2026.
  • CVA Family Office left its GE HealthCare share count unchanged in Q2 2026.
  • GE HealthCare made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #592 holding.
  • CVA Family Office first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • CVA Family Office's GE HealthCare position peaked at $60.2K in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.